Spindle cell rhabdomyosarcoma of bone with <i><scp>FUS</scp>–<scp>TFCP</scp>2</i> fusion: confirmation of a very recently described rhabdomyosarcoma subtype

Nooshi K Dashti(Mayo Clinic in Arizona), Rebecca N. Wehrs(Mayo Clinic), Brittany C. Thomas(Mayo Clinic), Asha Nair(Mayo Clinic), Jaime Davila(Mayo Clinic), Jan C. Buckner(Mayo Clinic in Arizona), Anthony P Martinez(Mayo Clinic in Arizona), William R. Sukov(Mayo Clinic in Arizona), Kevin C. Halling(Mayo Clinic), Benjamin M. Howe(Mayo Clinic in Arizona), Andrew L. Folpe(Mayo Clinic in Arizona)
Histopathology
May 14, 2018
Cited by 93

Abstract

AIMS: Rhabdomyosarcomas of bone are extremely rare, with fewer than 10 reported cases. A very rare subtype of spindle cell/sclerosing rhabdomyosarcoma harbouring a FUS-TFCP2 fusion and involving both soft tissue and bone locations has been reported very recently. We report only the fourth case of this unusual, clinically aggressive rhabdomyosarcoma. MATERIAL AND RESULTS: A previously well 72-year-old male presented with a destructive lesion of the mandible. Morphological and immunohistochemical study of a needle biopsy and the subsequent resection showed a spindle cell rhabdomyosarcoma. RNA-seq, RT-PCR and FISH confirmed the presence of the FUS-TFCP2 fusion. CONCLUSIONS: Spindle cell rhabdomyosarcomas carrying the FUS-TFCP2 fusion are very rare rhabdomyosarcoma variants with osseous predilection. The classification and differential diagnosis of this unusual molecular variant of spindle cell/sclerosing rhabdomyosarcoma are discussed.


Related Papers

No related papers found

Powered by citation graph analysis